The Daily Papule

Saturday 10 October

J DermatolLetterComment
Comment on "Achieving Targeted Combined Endpoints in Patients With Atopic Dermatitis: A Real-World Study".
Pan C, Wu LJournal of Dermatology
No abstractRead at publisher(opens in a new tab)
Derm Pract ConceptLetterComment
Reply to "Scabies Treatment Failure
Beyond Permethrin and Plastic Bags".
Azzolina V, Schauer F, … senior author Pilz ACDermatology Practical & Conceptual
No abstractRead at publisher(opens in a new tab)

Thursday 8 October

BJDComment
Comment on 'Why do Australian dermatologists screen for Strongyloides stercoralis before dupilumab?'.
Chen T, Varcoe H, Lee GBritish Journal of Dermatology
No abstractRead at publisher(opens in a new tab)
BJDEditorialComment
Releasing the brake
lipid control of CD1a-autoreactive T cells in atopic dermatitis.
Hasegawa T, Kabashima KBritish Journal of Dermatology
No abstractRead at publisher(opens in a new tab)

Tuesday 6 October

JAADLetterComment
Response to Vahabi et al., "Expanding the Perspective on Cutaneous Malignancy in Systemic Sclerosis Transplant Recipients
Comment on Kanwar et al.".
Kanwar R, Nambudiri VEJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)
JAADLetterComment
Response to Forman et al.'s "A randomized, double-blind, placebo-controlled phase 2 study of eltrekibart, a novel septa-specific monoclonal antibody to CXCR1/2 ligands, in adults with hidradenitis suppurativa.".
Zhang N, Xu MJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)

Monday 5 October

JAADLetterComment
Letter to the Editor re
"Minimally invasive modalities for keratinocyte carcinomas-Part I: Diagnostics".
Sholji T, Santos E Silva Caldeira Marques ML, Guitera PJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)
JAADLetterComment
Authors' response to Michelerio and Farnetani "Response to Navarrete-Dechent et al's 'Ultraviolet-induced fluorescent dermoscopy for the diagnosis of skin tumors: A multicenter study'".
Navarrete-Dechent C, Pietkiewicz P, … senior author Marghoob AAJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)
JAADLetterComment
Reply to Malhi and Singh
"Retinal Abnormalities in Alopecia Areata: A Systematic Review and Meta-Analysis".
Ameri K, Ashamalla M, … senior author Donovan JJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)
JAADLetterComment
Expanding the Perspective on Cutaneous Malignancy in Systemic Sclerosis Transplant Recipients
Comment on Kanwar et al.
Vahabi SM, Subhadarshani S, … senior author Grant-Kels JMJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)
JAADLetterComment
Response to Spangenberg and Koo, "Response to Schwarz C.W., et al. 'Comparative 2-year drug survival of bimekizumab and brodalumab in second-line treatment of psoriasis".
Schwarz CW, Loft N, Skov LJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)

Tuesday 29 September

Pediatr DermLetterComment
Letter to the Editor Re
The Association Between Isotretinoin Use and Suicidality in Adolescents: A Narrative Review.
Gaston J, Orchard DPediatric Dermatology
No abstractRead at publisher(opens in a new tab)

Monday 28 September

Exp DermEditorialComment
When Cold Gets Under the Skin
An Immunometabolic Circuit in Psoriasis.
Lee YI, Kim TGExperimental Dermatology
Read at publisher(opens in a new tab)
J Derm TreatComment
Commentary on benefit-risk profile comparison between dupilumab and upadacitinib
a structured benefit-risk assessment of the heads up trial.
Yılmaz E, Koker Özer N, Topal EJournal of Dermatological Treatment
No abstractRead at publisher(opens in a new tab)

Thursday 24 September

BJDComment
Reply to 'Caution in interpreting retrospective comparisons of acitretin and bexarotene in mycosis fungoides'.
Garfinkel V, Childs BA, … senior author Goff HWBritish Journal of Dermatology
No abstractRead at publisher(opens in a new tab)

Wednesday 23 September

BJDEditorialComment
Shared risk factors, divergent trends in keratinocyte carcinomas.
Cahoon EKBritish Journal of Dermatology
No abstractRead at publisher(opens in a new tab)
Pediatr DermLetterComment
Response to "Letter to the Editor Regarding 'Prospective Study to Assess the Utility and Validity of a Chromameter in the Assessment of Infantile Hemangiomas'".
Sánchez-Espino LF, Bahrani B, … senior author Pope EPediatric Dermatology
No abstractRead at publisher(opens in a new tab)
JAMA DermComment
Robustness of Network Meta-Analysis in Chronic Plaque Psoriasis-Reply.
Armstrong AW, Nong Y, Merola JFJAMA Dermatology
No abstractRead at publisher(opens in a new tab)
BJDComment
Reply to 'Cautious Interpretation of the Association Between Topical Corticosteroid Exposure and Type 2 Diabetes'.
Kim HN, Lee JH, … senior author Song SWBritish Journal of Dermatology
No abstractRead at publisher(opens in a new tab)

Tuesday 22 September

Clin Exp DermComment
Comment on 'Effectiveness, safety and tolerability of ozenoxacin 2% lotion vs clindamycin 1% lotion in mild to moderate truncal acne'
considerations regarding sample size and treatment-related withdrawal.
Liu S, Wang XClinical and Experimental Dermatology
No abstractRead at publisher(opens in a new tab)

Comment

Saturday 10 October

Thursday 8 October

Tuesday 6 October

Monday 5 October

Tuesday 29 September

Monday 28 September

Thursday 24 September

Wednesday 23 September

Tuesday 22 September